O efeito do treinamento com técnica de entrevista motivacional no autogerenciamento do diabetes, fatalismo na saúde e parâmetros metabólicos em indivíduos com diabetes tipo 2
The Effect of Motivational Interviews Based on the Health Belief Model on Self-Management Health Fatalism and Metabolic Parameters in Individuals With Type 2 Diabetes: Randomized Controlled Trial
This study aims to examine the effects on diabetes self-management, health fatalism and metabolic parameters of individuals with type 2 diabetes. The study will be conducted in a health institution between May 2025 and October 2025 and participants will be assigned to experimental and control groups by simple random sampling method. The experimental group will be trained with motivational interviewing techniques based on the health belief model for 8 weeks, followed by sending reminder SMS for 4 weeks. The control group will receive no intervention. The study is expected to improve the self-care behaviors of individuals with diabetes by creating positive effects on diabetes management and health fatalism.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Aim: The aim is to examine the effects of combining the Health Belief Model with Motivational Interviewing techniques on self-management behaviors, perceptions of health fatalism, and metabolic parameters in patients with type 2 diabetes.
Material and Method: This randomized controlled trial was conducted between July 2024 and April 2026. The sample consisted of a total of 62 individuals, including 31 experimental subjects and 31 controls. Data were collected using the "Identification Information Form," "Type 2 Diabetes Self-Management Scale", "Health Fatalism Scale" and "Metabolic Control Monitoring Form." In the experimental group, an 8-week training program based on the Health Belief Model and Motivational Interviewing was implemented; during the 4-week period following the training, support was provided via weekly SMS messages. No intervention was made in the control group. After 3 months, the scales were reapplied to both groups. The data were analyzed using SPSS 22, and t-tests, Mann Whitney U, Wilcoxon, and chi-square tests were used.
Conclusion: Motivational interviews based on the Health Belief Model have been found to increase self-management, reduce health fatalism, and improve metabolic parameters in individuals with type 2 diabetes. Accordingly, it is recommended that this approach be integrated into nursing practices in diabetes care, particularly in primary healthcare settings.
Key Words: Health belief model, health fatalism, metabolic parameters, motivational interviewing, nursing, self-management, type 2 diabetes
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Antalya, Turquia (Türkiye), 07000
- Manavgat and Aksu Family Health Center
-
Antalya, Turquia (Türkiye)
- Manavgat and Aksu Family Health Center
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Having type 2 diabetes for at least 6 months
- Being between 18 and 65 years old
- Have sufficient communication skills to answer verbal and written questions and fulfill instructions
- Becoming literate
- No physical, cognitive or mental impairment in answering the questions
- Willingness to participate in research.
Exclusion Criteria:
- Under 18 years of age
- Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process
- The emergence of any health problem that prevents the person from continuing the research
- Do not leave the study voluntarily.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Comparador Ativo: group receiving diabetes education with motivational interviewing technique
Patient Introduction Form, Type 2 DM Self-Management Scale (SMS) and Health Fatalism Scale will be applied to the experimental group before the training. then, diabetes education will be given to the individuals in the experimental group one day a week with the motivational interviewing technique based on the health belief model. 8 weeks of training will be given in total and then 4 weeks of informative reminder sms will be sent about diabetes education. After the training is over, Patient Introduction Form, Type 2 DM Self-Management Scale (SMS) and Health Fatalism Scale will be applied. |
individuals will receive diabetes education with motivational interviewing technique based on health belief model |
|
Sem intervenção: group with no intervention
The control group will be administered the Patient Introduction Form, Type 2 DM Self-Management Scale (SMS) and Health Fatalism Scale at the first encounter. After 3 months, the Patient Introduction Form, Type 2 DM Self-Management Scale (SMS) and Health Fatalism Scale will be applied again. No application will be made to the control group. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Type 2 DM Self-Management Scale (SMS)
Prazo: three months
|
The scale assesses self-management It has 3 sub-dimensions.These dimensions consist of 11 questions consisting of "Healthy Lifestyle Behaviors" dimension, consisting of 4 questions "Health Services Utilization" dimension and "Blood Sugar Management" dimension. Scoring: Always 5, Often 4, Sometimes 3, Rarely 2, Never 1. (-Healthy Lifestyle Subdimension= HLBD-1+ HLBD-2+ HLBD-3+ HLBD-4+ HLBD-5+ HLBD-6+ HLBD-7+ SYBD-8+ SYBD-9+ SYBD-10+ SYBD-11.) (-Blood Glucose Management Subscale= BSM-1+ BSM-2+ BSM-3+ BSM-4) (-Health Services Utilization Subdimension= SHK-1+ SHK-2+ SHK-3+ SHK-4) (-Diabetes Self-Management Scale score=SMDI Subdimension+CSM Subdimension +SCC Subdimension.) There are no reverse items in the scale. High scores indicate good self-management, low scores indicate and poor self-management. The minimum score that can be obtained from the Type 2 self-management scale is 19 and the maximum score is 95. |
three months
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Health Fatalism Scale
Prazo: three months
|
The scale consists of one sub-dimension and 17 items. The scale is a Likert-type scale answered as ''strongly disagree'', ''disagree'', ''undecided'', ''agree'', ''strongly agree''. The minimum score obtained from the Health Fatalism Scale is 17 and the maximum score is 85. Cronbach α Coefficient of the scale is 0.91.An increase in the score on the scale indicates an increase in fatalism. |
three months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- AU-SBF-GAÇ-01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .